Funder: National Institutes of Health
Due Dates: November 3, 2025 | May 4, 2026 (new, renewal, resubmission, revision)
Funding Amounts: Up to $475,000 in direct costs per year, for a maximum of 5 years (R01 mechanism)
Summary: Supports mechanistic, fundamental research using nanotechnology to address major barriers in cancer biology and oncology; clinical trials are not allowed.
Key Information: Projects must focus on mechanistic studies, not clinical translation; foreign organizations are not eligible to apply, but foreign components are allowed.